Augme Files Patent Infringement Suit Against Competitor Velti USA, Inc.
Complaint Filed in Delaware Seeks Permanent Injunction and Monetary Damages
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/12/12 -- (OTCBB: AUGT), ("Augme®") ("the Company"), a leader in interactive media marketing that provides the only patented end-to-end mobile marketing platform, today announced that it has filed a patent infringement lawsuit in the United States District Court of Delaware against Velti USA, Inc., (NASDAQ: VELT) (the "Defendant"), a global provider of mobile marketing and advertising technology and solutions.
Augme is asserting three causes of action involving patent infringement related to Augme-owned ("Method and Code Module for Adding Function to a Web Page"), ("Method and Code Module For Adding Function to a Web Page") and ("Method and System for Adding Function to a Web Page"). Augme seeks injunctive relief to prevent Defendant from continuing to infringe Augme's patents. In addition, Augme seeks a recovery of monetary damages resulting from Defendant's past infringement of these patents and all legal fees associated with this patent enforcement effort.
"Augme is fully committed to protecting the intellectual property rights provided by its growing patent portfolio," said Paul Arena, Chief Executive Officer of Augme Technologies, Inc. "We are taking this action on behalf of our shareholders to protect Augme's market-leading mobile marketing business from unfair practices by a direct competitor, and we expect to win damages, to be granted an injunction, and to be awarded legal fees."
Augme's Complaint alleges that it has suffered irreparable harm as a result of the alleged infringement and thus seeks a permanent injunction against Velti USA, Inc. The requested injunction would prevent Velti USA, Inc. from manufacturing, using, offering for sale, selling and/or importing into the United States of infringing products, methods, processes, services and/or systems that are primarily used or primarily adapted for use in an electronic or computer network system for targeting content via a Web browser. The Defendant's activities have been identified as infringing Augme's '721, '636 and/or '691 Patents, or otherwise inducing or contributing to the alleged infringement.
Augme® Technologies, Inc. (OTCBB: AUGT) provides strategic services and mobile marketing technology to leading consumer and healthcare brands. Selling its products and services under the Hipcricket brand, its platform, has provided measurable successes across an industry-leading 150,000+ campaigns for such clients as Macy's, MillerCoors, Nestle, and Clear Channel. Augme's offerings allow marketers, brands, and agencies to plan, create, test, deploy, and track mobile marketing programs across every mobile channel, including SMS, MMS, 2D/QR codes, mobile websites, advertising networks, social media and branded apps. Augme's platforms facilitate consumer brand interaction and the ability to track and analyze campaign results. Using its own patented device-detection and proprietary mobile content adaptation software, AD LIFE® solves the mobile marketing industry problem of disparate operating systems, device types, and on-screen mobile content rendering. Augme also provides business-to-consumer solutions, including national mobile couponing campaigns, strategic mobile healthcare tools, custom mobile application development, and consumer data tracking and analytics. In addition to AD LIFE®, Augme in 2011 acquired the assets of Hipcricket, Inc. and Jagtag, Inc. and licenses the digital broadcast platform BOOMBOX®. Augme is headquartered in New York City, with operations in Seattle, Atlanta, Dallas, Los Angeles, San Francisco, Chicago and Tucson. For more information, visit or .
Augme® Technologies, Inc., Hipcricket®, Augme®, AD LIFE®, BOOMBOX®, AD SERVE® and the Augme logo are trademarks of Augme Technologies, Inc. All rights reserved. 2009-12.
This release includes forward-looking statements. All statements regarding our expected future financial position, including management's revenue guidance, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in Augme's Form 10-K for the year ended February 28, 2011 and more recent reports and registration statements filed with the SEC. Augme Technologies, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter such forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
Stephanie Prince / Jody Burfening
LHA
(212) 838-3777
or
IP Communications Contact:
Bruce Berman
Brody Berman Associates
(212) 683-8125
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.03.2012 - 12:00 Uhr
Sprache: Deutsch
News-ID 123640
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Internet
Diese Pressemitteilung wurde bisher 212 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Augme Files Patent Infringement Suit Against Competitor Velti USA, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
Augme Technologies, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
